FDA Orange Book

Generic for Atelvia

Atelvia contains risedronate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

Yes. The generic name for Atelvia is risedronate. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.

Run it in Rivvi

Map Atelvia and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Atelvia products in the Orange Book

Atelvia products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
tablet, delayed release, oral35MGMarketed (Rx)AB1AB

NDA 022560, held by ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Approved generic risedronate

Approved generic versions of Atelvia
CompanyANDATE codeApprovedStrengths
TEVA PHARMACEUTICALS USA203217AB (A-rated, therapeutically equivalent)May 18, 201535MG

Atelvia patents

Patents listed for Atelvia
PatentExpiresCoversUse codeNDA
8246989January 16, 2026Drug productNone022560
7645460January 9, 2028Drug productU-662022560
7645459January 9, 2028Drug productU-662022560

Atelvia NDC codes

Questions

Is there a generic for Atelvia?

Yes. The generic name for Atelvia is risedronate. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.

What is the generic name for Atelvia?

The active ingredient in Atelvia is risedronate, per the FDA Orange Book.

When does the Atelvia patent expire?

The last patent listed for Atelvia in the Orange Book expires January 9, 2028. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Atelvia and Risedronate

Try it on your own data today.

Free to start. Most teams are using it the same day.